Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon : an 8-year retrospective cohort study (2006-2013)
| dc.contributor.author | Bigna, Jean Joel R | en_ZA |
| dc.contributor.author | Noubiap, Jean Jacques N | en_ZA |
| dc.contributor.author | Agbor, Ako A | en_ZA |
| dc.contributor.author | Plottel, Claudia S | en_ZA |
| dc.contributor.author | Billong, Serge Clotaire | en_ZA |
| dc.contributor.author | Ayong, André Patrick R | en_ZA |
| dc.contributor.author | Koulla-Shiro, Sinata | en_ZA |
| dc.date.accessioned | 2015-11-23T12:37:02Z | |
| dc.date.available | 2015-11-23T12:37:02Z | |
| dc.date.issued | 2015 | en_ZA |
| dc.description.abstract | BACKGROUND: Understanding contributors to mortality during the initial phase of tuberculosis (TB) treatment in patients co-infected with HIV would guide targeted interventions to improve survival. The aim of this study was to ascertain the incidence of death during the initial 2 months (new cases) and 3 months (retreatment cases) of TB treatment and to assess correlates of mortality in HIV co-infected patients. METHODS: We conducted a hospital-based retrospective cohort study from January 2006 to December 2013 at Yaoundé Central Hospital, Cameroon. We reviewed medical records to identify co-infected TB/HIV inpatients aged 15 years and older who died during TB treatment. Death was defined as any death occurring during TB treatment, as per World Health Organization recommendations. We collected socio-demographic, clinical and laboratory data. We conducted multivariable logistic binary regression analysis to identify factors associated with death during the intensive phase of TB treatment. Magnitudes of associations were expressed by adjusted odds ratio (a OR ) with 95% confidence interval. A p value < 0.05 was considered statistically significant. RESULTS: The 99 patients enrolled had a mean age of 39.5 (standard deviation 10.9) years and 53% were male. Patients were followed for 276.3 person-months of observation (PMO). Forty nine patients were died during intensive phase of TB treatment. Death incidence during the intensive phase of TB treatment was 32.2 per 100 PMO. Having a non-AIDS comorbidity (a OR 2.47, 95%CI 1.22-5.02, p = 0.012), having extra-pulmonary TB (a OR 1.89, 95%CI 1.05-3.43, p = 0.035), and one year increase in duration of known HIV infection (aOR 1.23, 95%CI 1.004-1.49) were independently associated with death during the intensive phase of TB treatment. CONCLUSIONS: Mortality incidence during intensive phase of TB treatment was high among TB/HIV co-infected patients during TB treatment; and strongly associated with extra pulmonary TB suggesting advanced stage of immunosuppression and non-AIDS comorbidities. Early HIV diagnosis and care and good management of non-comorbidities can reduce this incidence. | en_ZA |
| dc.identifier.apacitation | Bigna, J. J. R., Noubiap, J. J. N., Agbor, A. A., Plottel, C. S., Billong, S. C., Ayong, A. P. R., & Koulla-Shiro, S. (2015). Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon : an 8-year retrospective cohort study (2006-2013). <i>PLoS One</i>, http://hdl.handle.net/11427/15353 | en_ZA |
| dc.identifier.chicagocitation | Bigna, Jean Joel R, Jean Jacques N Noubiap, Ako A Agbor, Claudia S Plottel, Serge Clotaire Billong, André Patrick R Ayong, and Sinata Koulla-Shiro "Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon : an 8-year retrospective cohort study (2006-2013)." <i>PLoS One</i> (2015) http://hdl.handle.net/11427/15353 | en_ZA |
| dc.identifier.citation | Bigna, J. J. R., Noubiap, J. J. N., Agbor, A. A., Plottel, C. S., Billong, S. C., Ayong, A. P. R., & Koulla-Shiro, S. (2015). Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon : an 8-year retrospective cohort study (2006-2013). PloS one, 10(7), e0132394. doi:10.1371/journal.pone.0132394 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Bigna, Jean Joel R AU - Noubiap, Jean Jacques N AU - Agbor, Ako A AU - Plottel, Claudia S AU - Billong, Serge Clotaire AU - Ayong, André Patrick R AU - Koulla-Shiro, Sinata AB - BACKGROUND: Understanding contributors to mortality during the initial phase of tuberculosis (TB) treatment in patients co-infected with HIV would guide targeted interventions to improve survival. The aim of this study was to ascertain the incidence of death during the initial 2 months (new cases) and 3 months (retreatment cases) of TB treatment and to assess correlates of mortality in HIV co-infected patients. METHODS: We conducted a hospital-based retrospective cohort study from January 2006 to December 2013 at Yaoundé Central Hospital, Cameroon. We reviewed medical records to identify co-infected TB/HIV inpatients aged 15 years and older who died during TB treatment. Death was defined as any death occurring during TB treatment, as per World Health Organization recommendations. We collected socio-demographic, clinical and laboratory data. We conducted multivariable logistic binary regression analysis to identify factors associated with death during the intensive phase of TB treatment. Magnitudes of associations were expressed by adjusted odds ratio (a OR ) with 95% confidence interval. A p value < 0.05 was considered statistically significant. RESULTS: The 99 patients enrolled had a mean age of 39.5 (standard deviation 10.9) years and 53% were male. Patients were followed for 276.3 person-months of observation (PMO). Forty nine patients were died during intensive phase of TB treatment. Death incidence during the intensive phase of TB treatment was 32.2 per 100 PMO. Having a non-AIDS comorbidity (a OR 2.47, 95%CI 1.22-5.02, p = 0.012), having extra-pulmonary TB (a OR 1.89, 95%CI 1.05-3.43, p = 0.035), and one year increase in duration of known HIV infection (aOR 1.23, 95%CI 1.004-1.49) were independently associated with death during the intensive phase of TB treatment. CONCLUSIONS: Mortality incidence during intensive phase of TB treatment was high among TB/HIV co-infected patients during TB treatment; and strongly associated with extra pulmonary TB suggesting advanced stage of immunosuppression and non-AIDS comorbidities. Early HIV diagnosis and care and good management of non-comorbidities can reduce this incidence. DA - 2015 DB - OpenUCT DO - 10.1371/journal.pone.0132394 DP - University of Cape Town J1 - PLoS One LK - https://open.uct.ac.za PB - University of Cape Town PY - 2015 T1 - Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon : an 8-year retrospective cohort study (2006-2013) TI - Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon : an 8-year retrospective cohort study (2006-2013) UR - http://hdl.handle.net/11427/15353 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/15353 | |
| dc.identifier.uri | http://dx.doi.org/10.1371/journal.pone.0132394 | |
| dc.identifier.vancouvercitation | Bigna JJR, Noubiap JJN, Agbor AA, Plottel CS, Billong SC, Ayong APR, et al. Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon : an 8-year retrospective cohort study (2006-2013). PLoS One. 2015; http://hdl.handle.net/11427/15353. | en_ZA |
| dc.language.iso | eng | en_ZA |
| dc.publisher | Public Library of Science | en_ZA |
| dc.publisher.department | Department of Medicine | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en_ZA |
| dc.rights.holder | © 2015 Bigna et al | en_ZA |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | en_ZA |
| dc.source | PLoS One | en_ZA |
| dc.source.uri | http://journals.plos.org/plosone | en_ZA |
| dc.subject.other | Tuberculosis | en_ZA |
| dc.subject.other | HIV | en_ZA |
| dc.subject.other | Death rates | en_ZA |
| dc.subject.other | HIV infections | en_ZA |
| dc.subject.other | Tuberculosis diagnosis and management | en_ZA |
| dc.subject.other | Antiretroviral therapy | en_ZA |
| dc.subject.other | HIV diagnosis and management | en_ZA |
| dc.subject.other | Blood counts | en_ZA |
| dc.title | Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon : an 8-year retrospective cohort study (2006-2013) | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Bigna_Early_Mortality_2015.pdf
- Size:
- 729.53 KB
- Format:
- Adobe Portable Document Format
- Description: